Article
Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL.
Journal of lipid research - 1 Mar 2005
Albert Timothy S E, Duchateau Philippe N, Deeb Samir S, Pullinger Clive R, Cho Min H, Heilbron David C, Malloy Mary J, Kane John P, Brown B Greg
Abstract excerpt
Apolipoprotein L-I (apoL-I) is present on a subset of HDL particles and is positively correlated with plasma triglycerides (TGs). We measured plasma apoL-I levels in coronary artery disease (CAD) subjects with low HDL who were enrolled in an angiographic CAD prevention trial. At baseline, apoL-I levels (n = 136; range, 2.2-64.1 mug/ml) were right skewed with a large degree of variability. Multivariate analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.